Protecting patient access to discounted medications and health care services through Washington's health care safety net by preventing manufacturer limitations on the 340B drug pricing program.

Summary

The law prohibits drug makers, distributors, and logistics providers from denying or restricting 340B‑priced medicines to eligible safety‑net providers or their contract pharmacies, and bars them from demanding data as a condition for sales. It also requires covered entities to submit detailed annual 340B usage and savings reports, with civil penalties for violations. The measure aims to keep discounted drugs accessible to vulnerable Washington residents.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share